News

AMSilk fundraising will help meet market demand for biopolymers

11/04/2023

Synthetic silk biopolymer developer AMSilk has raised EUR 25 million in a financing round, which will help it to scale up production and meet commercial needs.  The German company’s technology platform, based on silk proteins, produces bio-fabricated materials that can be used for textile fibres, medical devices and consumer goods. Ulrich...

To continue reading this story, please sign in or register.

Related stories:

AMSilk secures €52 million to boost scale-up 09/09/2025
AMSilk heads to France 23/10/2024
Biotech silk readies for commercialisation 21/06/2024
The ‘untapped potential’ of natural and biotech fibres 19/06/2024
Partnership spins new chapter for ‘spider silk’ proteins 22/01/2024
AMSilk tailoring proteins for performance textiles 16/02/2023
Move to new HQ will support expansion, AMSilk says 02/11/2022
Biomaterials demand far exceeds supply - report 10/12/2020
AMSilk creates chief operating officer role for greater push towards brands 06/10/2020
AMSilk wants to fly higher 12/09/2018
AMSilk CEO to speak at San Francisco event 29/09/2017

Sportstextiles.com cannot be held responsible for content if the language setting is changed from English.

The translations provided by Google Translate are automated and therefore might not be accurate and may contain incorrect, offensive or misleading language. We offer this facility as a guide only.